Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Grace Lu-Yao"'
Autor:
Sean P. Stroup, Audry H. Robertson, Kayla C. Onofaro, Michael G. Santomauro, Nicholas R. Rocco, Huai‐ching Kuo, Avinash R. Chaurasia, Samantha Streicher, Darryl Nousome, Timothy C. Brand, John E. Musser, Christopher R. Porter, Inger L. Rosner, Gregory T. Chesnut, Anthony D'Amico, Grace Lu‐Yao, Jennifer Cullen
Publikováno v:
Cancer Medicine, Vol 11, Iss 24, Pp 4756-4766 (2022)
Abstract Background Previous research exploring the role of race on prostate cancer (PCa) outcomes has demonstrated greater rates of disease progression and poorer overall survival for African American (AA) compared to Caucasian American (CA) men. Th
Externí odkaz:
https://doaj.org/article/74909b5b479744bbba457ffd71414ccb
Autor:
Nathan Oehrlein, Samantha A. Streicher, Huai‐Ching Kuo, Avinash Chaurasia, Jacob McFadden, Darryl Nousome, Yongmei Chen, Sean P. Stroup, John Musser, Timothy Brand, Christopher Porter, Inger L. Rosner, Gregory T. Chesnut, Kayla C. Onofaro, Timothy R. Rebbeck, Anthony D’Amico, Grace Lu‐Yao, Jennifer Cullen
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4354-4365 (2022)
Abstract Background There is substantial variability in prostate cancer (PCa) mortality rates across Caucasian American (CA), African American (AA), Asian, and Hispanic men; however, these estimates are unable to disentangle race or ethnicity from co
Externí odkaz:
https://doaj.org/article/80095399a5ba4aa5b4182ef949372bbf
Autor:
Weelic Chong, Zhenchao Zhang, Rui Luo, Jian Gu, Jianqing Lin, Qiang Wei, Bingshan Li, Ronald Myers, Grace Lu-Yao, William Kevin Kelly, Chun Wang, Hushan Yang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background The neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and circulating tumor cells (CTCs) have been associated with survival in castration-resistant prostate cancer (CRPC). However, no study has examined the progn
Externí odkaz:
https://doaj.org/article/62868177e80a4dc7aef640713ce39d8b
Autor:
Grace Lu-Yao, Jennifer M Johnson, Amy L Shaver, Nikita Nikita, Swapnil Sharma, Daniel S Lefler, Atrayee Basu-Mallick, Meghan L Butryn
Publikováno v:
BMJ Open, Vol 12, Iss 7 (2022)
Introduction Immune checkpoint inhibitors (ICIs) have changed the treatment landscape for multiple cancer types. Sex plays an important role in both the development of cancer as well as the functioning of the immune system. Though a difference in res
Externí odkaz:
https://doaj.org/article/a89ece8d7e364f19ad3f325b086983d8
Autor:
Xiang‐Lin Tan, Jian‐Yu E, Yong Lin, Timothy R. Rebbeck, Shou‐En Lu, Mingyi Shang, William K. Kelly, Anthony D'Amico, Mark N. Stein, Lanjing Zhang, Thomas L. Jang, Isaac Yi Kim, Kitaw Demissie, Anna Ferrari, Grace Lu‐Yao
Publikováno v:
Cancer Medicine, Vol 9, Iss 7, Pp 2379-2389 (2020)
Abstract Background Pre‐clinical studies suggest that metformin and statins may delay prostate cancer (PCa) metastases; however, data in humans are limited. To the best of our knowledge, this is the first human study aimed to quantify the individua
Externí odkaz:
https://doaj.org/article/c2361380119f40b3a468055abbe17f57
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273826 (2022)
IntroductionAbiraterone acetate and enzalutamide are commonly employed in prostate cancer therapy in an interchangeable manner. These drugs are highly efficacious in androgen antagonism to improve patient outcomes, but they also carry noteworthy risk
Externí odkaz:
https://doaj.org/article/fed110b9024a470b95c339c41552ce14
Publikováno v:
Cancers, Vol 14, Iss 18, p 4502 (2022)
Arsenic is a crucial environmental metalloid whose high toxicity levels negatively impact human health. It poses significant health concerns to millions of people in developed and developing countries such as the USA, Canada, Bangladesh, India, China
Externí odkaz:
https://doaj.org/article/53582f2431b744dda9d3fd8af7ff2cf5
Autor:
Yash B. Shah, Amy L. Shaver, Jacob Beiriger, Sagar Mehta, Nikita Nikita, William Kevin Kelly, Stephen J. Freedland, Grace Lu-Yao
Publikováno v:
Cancers, Vol 14, Iss 15, p 3773 (2022)
Abiraterone acetate (AA) and enzalutamide (ENZ) are commonly used for metastatic prostate cancer. It is unclear how their outcomes and toxicities vary with patient-specific factors because clinical trials typically exclude patients with significant c
Externí odkaz:
https://doaj.org/article/cb3dbb0149ba41aaaf7aea2dd5f03a02
Autor:
Nikita Nikita, Joshua Banks, Scott W. Keith, Andrew Song, Jennifer M. Johnson, Melissa Wilson, Swapnil Sharma, Grace Lu-Yao
Publikováno v:
Cancers, Vol 14, Iss 5, p 1296 (2022)
Immune checkpoint inhibitors (ICIs) harness the immune system and are the therapy of choice for multiple cancers. Although immunosuppressive agents such as steroids are also used in many cancers, it is unknown how their timing affects treatment outco
Externí odkaz:
https://doaj.org/article/105c8c9bfd4a445e84fc8baaa16182ba
Autor:
Amy L. Shaver, Swapnil Sharma, Nikita Nikita, Daniel S. Lefler, Atrayee Basu-Mallick, Jennifer M. Johnson, Meghan Butryn, Grace Lu-Yao
Publikováno v:
Cancers, Vol 13, Iss 24, p 6364 (2021)
Background: Cancer therapies are associated with multiple adverse effects, including (but not limited to) cancer-related fatigue (CRF). Fatigue is one of the most common side effects of immune checkpoint inhibitors (ICIs), occurring in up to 25% of p
Externí odkaz:
https://doaj.org/article/d03da42ec3e04552bab52d5c88a79e71